Clinical trial SIENDO/ENGOT-EN5
A randomized phase III trial of maintenance with Selinexor / placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer
Cancers | |
---|---|
Organ | Endometrium |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Karyopharm |
EudraCT Identifier | 2017-000607-25 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03555422 |
Last update |